Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Depreciation & Amortization (CF) (2019 - 2025)

Historic Depreciation & Amortization (CF) for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to $248253.0.

  • Volitionrx's Depreciation & Amortization (CF) fell 1290.53% to $248253.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 588.85%. This contributed to the annual value of $1.1 million for FY2024, which is 341.42% down from last year.
  • As of Q3 2025, Volitionrx's Depreciation & Amortization (CF) stood at $248253.0, which was down 1290.53% from $252688.0 recorded in Q2 2025.
  • Over the past 5 years, Volitionrx's Depreciation & Amortization (CF) peaked at $296587.0 during Q4 2023, and registered a low of $224310.0 during Q1 2022.
  • Over the past 5 years, Volitionrx's median Depreciation & Amortization (CF) value was $251941.0 (recorded in 2025), while the average stood at $257897.4.
  • Per our database at Business Quant, Volitionrx's Depreciation & Amortization (CF) skyrocketed by 4270.15% in 2021 and then crashed by 1290.53% in 2025.
  • Volitionrx's Depreciation & Amortization (CF) (Quarter) stood at $236847.0 in 2021, then grew by 5.12% to $248968.0 in 2022, then grew by 19.13% to $296587.0 in 2023, then fell by 0.32% to $295642.0 in 2024, then fell by 16.03% to $248253.0 in 2025.
  • Its last three reported values are $248253.0 in Q3 2025, $252688.0 for Q2 2025, and $251941.0 during Q1 2025.